sICAM-1和sVCAM-1血清水平对早期妊娠高血压的诊断价值研究

doi:10.3969/j.issn.1006-6233.2021.11.011

Abstract
Figure/Table
References
Related Citation (6)

Download: PDF (1198 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To research the value of serum sICAM-1 and sVCAM-1 levels in the early diagnosis of hypertension during pregnancy (HDCP). Methods: The blood pressure and serum levels of sICAM-1 and sVCAM-1 in 450 pregnant women were monitored dynamically. The patients were divided into normal group and HDCP group according to the rise of blood pressure. Analysising the relationship between the changes of serum levels of sICAM-1, sVCAM-1 and HDCP. The threshold value of serum sVCAM-1 level(±s)in normal group was used as the diagnostic threshold of HDCP. Verifying the accuracy of the method. Results: The elevation of blood pressure in HDCP group occurred at 20 weeks of gestation and later, 57 of 450 pregnant women had HDCP, the incidence was 12.67%;Serum sICAM-1 and sVCAM-1 in HDCP group increased significantly at 10 weeks of gestation compared with normal group (P<0.05).The level of systolic blood pressure after 20 weeks in HDCP group was positively correlated with the level of serum sVCAM-1 during pregnancy (r=0.754, P<0.05);The value of serum sVCAM-1 level(±s) at 10 weeks in normal group was (1136.8+253.8) ng/mL. The specificity based on this diagnosis is 83.2%, and the sensitivity is 90.6%. Conclusion: Monitoring serum sICAM-1 and sVCAM-1 can early diagnose HDCP. It has the characteristics of convenient sampling, accurate method and sensitivity.

Key words： Hypertension in pregnancy Early diagnosis Serum ICAM-1 Serum VCAM-1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Yanjun
	YANG Shifang
	ZHANG Nana
	et al

Cite this article:

CHEN Yanjun,YANG Shifang,ZHANG Nana, et al. The Value of Serum Levels of sICAM-1 and sVCAM-1 in the Early Diagnosis of Pregnancy-Induced Hypertension[J]. HeBei Med, 2021, 27(11): 1817-1820.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2021.11.011 OR http://www.hbyxzzs.cn/EN/Y2021/V27/I11/1817

[1] 于鲁华,赵爱,孔艳,等.妊娠期高血压疾病孕妇血清25-羟维生素D、可溶性fms样酪氨酸激酶1水平变化及与妊娠结局的关系[J].中国临床医生杂志,2021,49(9):1108~1111.
[2] 陈益明,卢莎,顾琳媛,等.中孕期血清可溶性血管内皮生长因子受体1、胎盘生长因子水平及其比值筛查妊娠期高血压疾病的效率[J].中国卫生检验杂志,2020,30(4):434~438.
[3] 李晓琼,季东林,胡海琴,等.孕早期胎盘生长因子、同型半胱氨酸及血管内皮生长因子对妊娠期高血压疾病的预测价值[J].中国妇产科临床杂志,2020,21(1):87~88.
[4] 刘前,邓倩,陈凯.活化白细胞黏附分子与血小板内皮细胞黏附分子-1在2型糖尿病并发急性脑梗死患者中的变化及意义[J].中国实用神经疾病杂志,2021,24(7):578~584.
[5] 武进华,贾林萍.茜根散联合糖皮质激素对过敏性紫癜患儿可溶性细胞间黏附分子-1、可溶性血管细胞黏附分子-1表达水平的影响[J].现代中西医结合杂志,2017,26(14):1502~1504.
[6] 谢幸,孔北华,段涛.妇产科学[M].北京:人民卫生出版社,2018.83.
[7] Benschop L, Duvekot J.J, Roeters van Lennep J.E. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy[J]. Heart, 2019, 105(16): 1273~1278.
[8] Coroyannakis C, Khalil A. Management of hypertension in the obese pregnant patient[J]. Curr Hypertens Rep, 2019, 21(3): 24.
[9] 于春磊,唐宋琪,李晓明,等.莪术对血瘀证和正常孕大鼠血液及子代脑组织神经黏附分子基因表达的影响[J].中医学报,2018,33(10):1966~1969.
[10] 侯凌波,李论,成忠.妊娠期高血压疾病患者血清血小板内皮细胞黏附分子1和人可溶性血管内皮生长因子受体1的水平[J].中华高血压杂志,2019,27(8):776~778.
[11] Alma L.J, De Groot C.J.M, De Menezes R.X, et al. Endothelial dysfunction as a long-term effect of late onset hypertensive pregnancy disorders: High BMI is key[J]. Eur Obstet Gynecol Reprod Biol, 2018, 6(225): 62~69.
[12] 罗希,赵锦秀,田恬.子痫前期患者血清sICAM-1、PAPP-A、VEGF表达及预测价值[J].中国计划生育学杂志,2021,29(4):815~818.
[13] de Alwis N, Beard S, Mangwiro Y.T, et al. Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction[J]. Pregnancy Hypertens, 2020, 5(20):83~91.
[14] Tanlai Z, Sytze R, Frank C.T,et al. Blood pressure variability and microvascular dysfunction: the maastricht study[J]. Journal of Hypertension Publish Ahead of Print,2020,38(8):1541~1550.